Hygiene and health company Essity has seen a positive share price trend following its interim report on Thursday, January 22, which delivered better-than-expected results. The deviation in EBITA was positive at 2.2%.

The share, which dropped 7.4% on the day of the report, is currently up 1.8% since the release, while the large-cap OMXS30 index has risen by 4.5%.

Based on estimates received after the interim report, Factset's consensus for this year's sales has been lowered by 2.4%, while next year's consensus has been adjusted down by 2.5%.

Consensus for the adjusted EBITA result has been reduced by 1.3% for this year and by 1.7% for next year.

The average recommendation for the stock remains overweight.

The average target price has been cut by 2.1% to 281.38 kronor, down from 287.44 kronor.

The proportion of positive recommendations now stands at 39% (previously 44%), while the proportion of hold recommendations is 50% (44%), and negative recommendations remain unchanged at 11% (11%).


Essity
Share price movement on report day (B share)-7.4%
Date2026-02-092026-01-21DifferenceNumber of estimates
Share price276.40271.401.8%
Average target price281.38287.44-2.1%
Difference target price vs current share price1.80%5.91%
Consensus recommendationOverweightOverweight18
Proportion of positive recommendations39%44%7
Proportion of hold recommendations50%44%9
Proportion of negative recommendations11%11%2
Sales, current year137 147140 481-2.4%14
Sales, next year141 016144 565-2.5%14
Sales growth, next year2.8%2.9%
Adjusted EBITA, current year19 73920 008-1.3%10
Adjusted EBITA, next year20 64820 997-1.7%10
Adjusted EBITA growth, next year4.6%4.9%
Source: Factset